Back to companies
Vir Biotechnology, Inc.
VIRUSNASDAQPharmaceuticals & HealthcareVir Biotechnology, Inc.
Revenue
$68.6mn
YoY -7.6%
Operating income
-$479.3mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API